Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin

Eur Urol. 2021 Feb;79(2):222-224. doi: 10.1016/j.eururo.2020.09.018. Epub 2020 Oct 2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Transitional Cell*
  • Cisplatin / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Doxorubicin / adverse effects
  • Gemcitabine
  • Humans
  • Methotrexate / adverse effects
  • Muscles
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / surgery
  • Vinblastine / adverse effects

Substances

  • Deoxycytidine
  • Vinblastine
  • Doxorubicin
  • Cisplatin
  • Methotrexate
  • Gemcitabine